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Treatment of psoriasis with dialysis. S. Caglar, S. Akkaya, F.
Kolemen, U. Yasavul, and I. Tasdemir. Hacettepe University
School of Medicine, Department of Medicine and Dermatology,
Ankara, Turkey. Psoriasis is a disease of unknown etiology, and
it is chronic and resistant to treatment most of the time. Four
patients were dialyzed after psoriasis had persisted for a long
time. The symptoms of three patients cleared after dialysis, but
the third patient had to undergo dialysis a second time. All four
patients now remain clear after I to 5 months. Psoriasis did not
recur in that time.
Investigation of 3'-5'-cyclic AMP in patients with chronic renal
failure and on regular hemodialysis. A. E. Ertug, S. Kologlu, L.
B. Kologlu, B. Erbay, V. Aral, and G. Yakupoglu. Departments
of Internal Medicine, Endocrinology, and Metabolism, Ankara
University School of Medicine, Ankara, Turkey. In 12 patients (7
males and 5 females; mean ages, 39.8 yr) with end-stage renal
failure (ESRF) and in 23 patients (15 males and 8 females; mean
ages, 35.8 yr) on regular hemodialysis, serum cAMP levels to-
gether with some hormones were investigated. In the first group,
mean set-urn creatinine levels were 11.5 6.5 mg/dl and mean
serum cAMP levels were 16.55 18.5 pmoles/ml (normal, 10.43
7.48pmoles/rnl). Pt-c- and post-dialysis mean serum cAMP lev-
els were 13.30 8.32 pmoles/ml, and 14.56 19.32 pmoles/ml,
respectively. In patients with ESRF, serum cAMP levels had in-
creased but had not been influenced by one hemodialysis treat-
ment. When the cases were investigated one by one together
with some hormones, it was observed that the post-dialysis
serum cAMP and insulin levels decreased in 14 patients, and in 8
patients blood glucose levels showed a distinct decrease but
paradoxically serum cAMP and plasma insulin levels increased.
Kidney transplantation. M. Haberal, N. Buyukpamukcu, U.
Saatci, R. Yalin, H. Kocak, .. caglar, and N. Bilgin. Hacettepe
University Hospital Transplantation Unit, Ankara, Turkey.
From November 1975 to 1979, 88 kidneys have been trans-
planted to 85 patients. Of 88 transplanted kidneys, 75 (85.2%)
were living related and 13 (14.7%) cadaver. In 75 cases, first-year
graft function for transplanted kidneys were 80%, which were
taken from mother donors, 70% sibling donors, 60% father do-
nors, and 20% cadaver donors. According to tissue antigens,
first-year graft function was 85% in 4 antigen-compatible pa-
tients, 65% in 3 antigen-compatible patients, and 60% in 2 anti-
gen-compatible patients. In this series, acute rejection rate was
26.6%, chronic rejection 40%, and overall mortality 34.6%. The
main causes of mortality were infection (34.6%), hepatitis
(11.5%), others (53.8%).
Living related renal transplantation in Ankara University Medi-
cal School. T. Karpuzoglu, A. Yaycioglu, E. Ertug, B. Erbay, G.
Yakupoglu, N. Aras, N. Oygür, and M. Akaydin. Department of
Surgery and Medicine, Ankara University Faculty of Medicine,
Ankara, Turkey. Since November 1978, 17 patients with end-
stage renal disease have been treated by living related renal
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transplantation in our hospital. All but two kidney recipients
were male. The youngest recipient was 21, and the oldest one
was 46 years old. The average age of the recipients was 32.4
years. Of the donors, 9 were male and 8 were female. The young-
est donor was 18 and the oldest one was 61 years old. Average
age of the donors was 37.8 years. Of the donors, 11 were siblings,
and 6 were parents. In terms of HLA antigens matching, 13 of
the donor-recipient pairs were haploidentical and 4 were fully
identical. Our only operative complication was stenosis at ure-
teroneocystostomy due to technical failure, which necessitated
reoperation. During the followup period; I lymphocele, 1 jaun-
dice due to azathioprine, 2 localized abscesses, I penanal viral
condyloma, and I perioral herpetiform lesion were noted and
treated successfully. One of the 17 patients died in his 4th post-
operative month.
Role of dipyridamole in hemodialysis. H. Kocak, U. Saatci,
and G. Hicsonmez. Hacettepe Children's Hospital, Hacettepe
University, Ankara, Turkey. In this study the effectiveness of pyr-
idamole in reducing platelet aggregation and in increasing mem-
brane efficiency in dialysis was evaluated. Ten chronic hemo-
dialysis patients were studied during 2 consecutive hemodialysis
periods. In one period, dipyridamole was used. Coil pressure,
dialysate, and blood flow were kept constant for all patients
throughout the study. In vivo platelet aggregation, BUN, and
creatine dialyzance were measured at the beginning, middle, and
end of each hemodialysis period. In all patients, when dipyrida-
mole was used, in vivo platelet aggregation was lower and BUN
and creatine dialysis values were higher than without dipyrida-
mole. This study suggestes that dipyridamole is effective in re-
ducing in vivo platelet aggregation and in increasing BUN and
creatine dialyzance in hemodialysis patients.
Alterations of endocrinologic functions in patients with chronic
renal failure and on regular hemodialysis (before and after dial-
ysis). S. Kologlu, A. E. Ertug, L. B. Kologlu, V. Aral, B. Erbay,
and G. Yakupoglu. Departments of Internal Medicine, Endocri-
nology, and Metabolic Diseases, Ankara University School of
Medicine, Ankara, Turkey. Endocrine function tests were done
on the following by RIA method: Group 1 was comprised of 12
terminal renal failure (TRF) patients with an average age of 39.8
years, 7 of whom were male and the rest female. Group 2 re-
ceived regular hemodialysis treatment (RHT) and was comprised
of 15 male and 8 female patients with an average age of 35.8
years. Group 1 (TRF) had normal FSH, TSH, T4 values, higher
STH, LH, prolactin, insulin, plasma cortisol, and aldosterone
levels and lower testosterone and T3 levels compared with nor-
mal. In RHT patients, no outstanding difference was noted in
male patients other than the increased levels of plasma cortisol
and T3. With single hemodialysis, a remarkable inverse was
noted in prolactin and T4 levels.
Effects of aspirin on kidney functions. S. Kucukoduk and U.
Saatci. Department of Pediatrics, Hacettepe University, School
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of Medicine, Ankara, Turkey. This study was carried out on 16
children who did not have any renal disease according to their
physical and simple urine examination. Aspirin was given, 25
mg/kg of body wt, orally every 6 hours for 7 days, Before and
after aspirin treatment, BUN, creatinine, endogenous creatinine
clearance (Ccr), urinary osmolality, and urinary prostaglandin E2
(PGE2) activity were investigated. C. and PGE2 values were sig-
nificantly lower (P < 0.001, P < 0.01) and urinary osmolality
value was higher after aspirin treatment. This study indicates
that therapeutic doses of aspirin affects some renal functions.
Effects of estrogen on normal kidney morphology and on the
experimental pyelonephritis in rats. 0. Manavoglu. Department
of Internal Medicine, Bursa University Medical Faculty, Bursa,
Turkey. Effects of estrogen application on the kidney morpholo-
gy and its predisposing action on the experimental unilateral E.
coli pyelonephritis were studied in 110 rats. Estrogen was ap-
plied at different periods of time to rats. We observed that estro-
gen yielded a "nonspecific nephropathy" or at least a serial mor-
phologic changes in normal kidney tissue, which can be accepted
as a predisposing factor in the pathogenesis of pyelonephritis. In
addition, this finding correlates well with the estrogen appli-
cation period.
Five years' experience in experimental pyelonephritis. A. Obek,
S. Peynircioglu, M. Yurtkuran, and Y. Yücel. University of Bur-
sa, Medical Faculty, Department of Internal Medicine, Bursa,
Turkey. Hematogeneous bilateral Staph. aureus pyelonephritis
(Py) and unilateral (direct inoculation) F. coli Py were induced in
705 albino rats. We studied the changes in GFR and max Uom lfl
Py; effects of water diuresis (WD) on Py; effects of WD on max
U0; effects of antibacterial agents (ABA) on Py; and effects of
WD-ABA on Py. Our results were: (1) Max Uosm decreased sig-
nificantly in Py where GFR was preserved. (2) WD has a positive
effect on prevention of Py. (3) There is a need for 2 days of nor-
mal hydration prior to the test, because of the negative effect of
WD on max Uom. (4) There may nt always occur a correlation
between the in vivo and in vitro effects of ABA. (6) There is a
potential effect of WD on the ABA. (7) Although gentamycin and
TMP-SMZ combination were effective in prevention of Py,
TMP, SMZ, suiphamethisole or sulphaethydole alone were not
sufficiently effective.
Lipoprotein changes before and after hemodialysis in patients
with chronic renal failure. M. Ozüer, 0. Berk, and E. Isik. De-
partment of Medicine, Gülhane Academy, Ankara, Turkey. We
evaluated pre and postdialysis blood biochemistry and lipopro-
teins in 20 chronic renal failure patients. The following parame-
ters of blood values are compared: azotemia, creatininemia, total
lipids, tryglycerides, cholesterol, total proteins, serum proteins
fractions, and lipoproteins fractions. There was remarkable de-
clines in azotemia, creatininemia, total lipids, tryglycerides, and
pre f3-lipoprotein after dialysis (P < 0.001), and also significant
reduction in total proteins, cholesterol, albumin, y-globulins (P
<0.05). Pre and postdialysis values in a-i ,a-2 and /3 fractions of
serum proteins, and also aj3-lipoproteins were not significantly
different (P> 0.05). These findings were compared with previous
studies in the literature.
immunosuppressive therapy in nonspecific glomerulonephri-
tides. S. Peynircioglu, Y. Yiicel, M. Yurtkuran, and A. Ohek.
University of Bursa, Medical Faculty, Department of Internal
Medicine, Bursa, Turkey. Effects of immunosuppressive (IMS)
therapy on the course of nonspecific glomerulonephritides (GN)
was studied in 21 cases (9 membranoproliferative GN, 7 mesan-
gioproliferative GN, 4 unclassified chronic GN and 1 focal scle-
rosing GN). Duration of the therapy was 6 to 24 months, and the
followup periods varied between 6 months and 5 years. IMS ther-
apy was evaluated by clinical progression, laboratory values, and
histopathologic changes (by frequent renal biopsies). Cyclophos-
phamide (C) and prednisolone (P) combination was used in gen-
eral, except in 3 cases where C substituted for azathioprine. In 6
cases with renal insufficiency, therapy was continued with C
alone, because of side-effects of P. It is concluded that non-
specific GN may respond favorably to IMS therapy, and thus,
this chance should always be given to all patients with non-
specific GN.
Hyperlipidemia in chronic renal failure. G. I. Russell, T. G.
Davies, andJ. Walls. Area Renal Unit, Leicester General Hospi-
tal, England. To investigate the hyperlipidemia in chronic renal
failure (CRF) we performed iv. fat tolerance tests (IVFTT) in
uremic patients treated conservatively (25) and by hemodialysis(32) together with controls (17). The fractional removal rate of
triglyceride (K2) is decreased in uremia and inversely correlated
with erum triglyceride and blood sugar, which were significant-
ly increased compared to controls. There appear to be two
groups of patients: (a) hyperlipidemia and low K2 where defec-
tive clearance of triglyceride was the major etiologic factor and
(b) hyperlipidemia and normal K2 where other factors are more
important.
Raised plasma myoinositol levels in uremia and experimental
neuropathy. A. San, N. Kocak, S. Cengiz, U.Tan, I.U.T.F. De-
partment of Internal Medicine and Atatürk U.T.F. Department
of Internal Medicine, Erzurum, Turkey. Plasma myoinositol (M)
levels and motor nerve conduction (MNCV) were determined in
17 cases of chronic renal failure (CRF) and in control subjects.
Levels of M were high and levels of MNCV were low in CRF. M
levels were measured in five cases of chronic hemodialysis and
seven cases of peritoneal dialysis before and after dialysis. In
both groups there was a significant fall in the levels of plasma M
after dialysis. A certain amount of M was given i.p. to five cats
for 14 days. In the beginning and end of the experiment, MNCV
was determined, and raised levels of M and lowered levels of
MNCV were found. There was segmental demyelinization in the
nerve biopsy specimens taken from these animals. This study
indicates that raised M levels should be considered as an impor-
tant factor in the formation of uremia neuropathy.
Surgical complications in renal transplantation. I. Sayek, R.
Yalin, and M. Haberal. Hacettepe Medical School, Ankara, Tur-
key. Eighty-eight kidney transplantations were performed at the
Hacettepe University Hospital's Department of Surgery Trans-
plantation Unit in a 4-year period (Nov. 1975-1979). Of the 88
transplantations, 75 (85.1%) were from related and 13 (14.9%)
from cadaver donors. The patients were followed from 3 months
to 4 years. Seven patients developed vascular (7.9%), 18 infec-
tious (20.4%), and 3 urologic complications. Of 15 patients who
underwent graft nephrectomy, bleeding into the wound was seen
in 2(13.3%) and wound infection in 8 (57.1%) patients. The com-
plications and their management are discussed.
Effect of alternate-day steroid therapy on hypertension of renal
transplant. H. Tanboga, University of Newcastle on Tyne, Great
Britain. Plasma renin activity (PRA), plasma and urinary aldoste-
rone, and exchangeable sodium (NaE,J were measured in 20 nor-
motensive and 26 hypertensive renal transplant patients during
daily and changing alternate-day prednisone therapy. The results
and mean arterial pressure were compared in both therapies. Af-
ter 3 months of alternate-day prednisone therapy, 80% of hyper-
tensives were normotensive or they reduced the doses or the
numbers of antihypertensives. PRA was higher in the hyperten-
sive than the normotensive group, but in both it was lower than
in a normal control population (P < 0.01) while taking daily pred-
nisone. Alternate-day therapy resulted in reduction of PRA in
both groups of renal transplant recipients (P < 0.05). The rela-
tionship between PRA and mean arterial pressure was no longer
present when changing the therapy. There was no difference in
plasma aldosterone between renal transplants and normal popu-
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lation. A positive correlation between PRA and PA disappeared
after changing therapy in hypertensive patients. There was no
correlation between urinary aldosterone, NaEX, and blood pres-
sure. PRA appeared to be an important factor in the reduction
blood pressure of renal transplant patients.
Urinary hydroxyprolin in chronic renal failure. F. Tanman, S.
Emre, A. Sirin, and T. Yesilbek. Pediatric Nephrology Depart-
ment, Medical Faculty of University of Istanbul, Istanbul, Tur-
key. Hydroxyprolin is an amino acid formed within the collagen
tissue and occurs significantly only in collagen. Urinary excre-
tion of hydroxyprolin may be regarded as an index of collagen
metabolism and indirectly as an index of growth and develop-
ment. In chronic renal failure, hydroxyprolin excreation is not an
index of growth, but rather an index of secondary hyper-
parathyroidism and renal osteodystrophy accompanying chronic
renal failure. In this study, with the aim of investigating whether
hydroxyprolin can be an index of growth in patients with chronic
renal failure under supportive therapy, the relationship of uri-
nary hydroxyproline excretion levels with various parameters
(bone age, calcium phosphorous, alkaline phosphatase, total ni-
trogen, urea, and creatinine in sera and urine samples) are inves-
tigated, compared with a control group, and results are dis-
cussed.
Relationship between serum proteins, creatinine levels, and diet
in chronic hemodialysis patients. Mustafa Yurtkuran and Selcuk
Kücukolu, Bursa Medical Faculty, Department of Nephrology
and Hypertension, Bursa, Turkey. Effects of different proteins,
including diets, on serum levels of a2-macroglobulin, a1-acid-
glycoprotein, albumin, transferrin, IgA, IgG, 1gM, C3 were in-
vestigated in chronic hemodialysis patients, dividing them into
five groups. Patients were observed for 3 months in each group.
In each group, 1 g/kg/day of protein and 0.7 g/kg/day of protein +
protein free on the hemodialysis days, and serum levels of urea
and creatinine were as high as those in the protein-free group,
although protein levels were in normal limits. In the 0.7 g/kgIday
of protein + essential amino acid group, serum levels of urea and
creatinine were significantly lower than the others, although
serum transferrin levels of this group were the highest. Thus, our
experiments suggest that the diet of this last group may be ac-
cepted as the best for chronic hemodialysis patients.
Androgen-induced hepatocell carcinoma in a hemodialysis pa-
tient. D. Zevin, H. Turani, and J. Levi. Nephrology Unit and
Department of Pathology, Hasharon Hospital, and the Tel Aviv
Medical School, Petach Tikva, Israel. Association between
anemia and renal failure has been recognized since the original
observation of Bright. Although erythropoiesis may improve
with regular hemodialysis, anemia continues to be one of the ma-
jor manifestations that persists to be a problem of many uremic
patients. Bernstein in 1971 described a case of hepatocell carci-
noma (HCC) in a patient with Fanconi's anemia treated with 17-
alkylated anabolic steroids (oxymethalone), and since that, 20
more cases were reported. We report here the first patient on
hemodialysis who had been on oxymethalone for 18 months and
developed HCC 20 months after discontinuation of the drug. The
tumor progressed very rapidly. The clinical and experimental
data support the theisis that an "androgenic environment" in the
absence of primary liver disease favors the development of
HCC. It is well recognized that there is an increase of malig-
nancies in chronic uremia and in patients on hemodialysis treat-
ment. Thus, more studies should be carried out to determine the
efficiency of androgenic anabolic steroids in an effort to reduce
the exposure of this group of patients to any possible carcino-
genic drugs.
